Another study is adding to the evidence that shingles vaccines are associated with a reduced risk of dementia. A real-world study, published online as a manuscript on Feb. 9, 2026, in Nature ...
News-Medical.Net on MSN
Study suggests shingles vaccine may help lower Alzheimer’s and dementia risk
By Hugo Francisco de Souza New real-world evidence links shingles vaccination with reduced dementia risk, raising important questions about viral triggers, inflammation, and future prevention ...
Research suggests it could prevent and slow the progress of cognitive decline. Read more at straitstimes.com. Read more at straitstimes.com.
Research from Canada shows that people vaccinated against shingles have a lower dementia risk. There may be a catch, however.
Every three seconds, someone, somewhere in the world, develops dementia. The number of people living with the condition is ...
There’s so much talk about vaccines these days, it’s helpful to review which ones are the most proven and recommended, and when we should get them. One important vaccine your healthcare provider may ...
MedPage Today on MSN
Dementia and the shingles vaccine: What a new study in Canada found
How varicella zoster virus vaccination may provide protection remains a mystery ...
A Canadian natural experiment analysis found herpes zoster vaccination was associated with fewer incident dementia diagnoses ...
Shingles is a medically termed herpes zoster. The name derives from the Latin term for belt. This is because Shingles generally results in a belt shaped rash. (6) Shingles is characterized by this ...
Read this article in HINDI. Shingles is a chronic skin infection that mainly afflicts adults. It is caused by the herpes zoster virus which is also called varicella-zoster and this same virus is ...
Shingles, also known as herpes zoster or just zoster, occurs when a virus in nerve cells becomes active again later in life and causes a skin rash. The virus that causes shingles, the varicella-zoster ...
The antiviral drug valaciclovir (Valtrex), given prophylactically, kept patients with systemic lupus erythematosus (SLE) under treatment with anifrolumab (Saphnelo) from having herpes zoster attacks, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results